REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ncage Therapeutics Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Rental and Leasing Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Educational Support Services | All Other Miscellaneous Ambulatory Health Care Services | Administration of Economic Programs
Full name: Ncage Therapeutics Sp. z o.o. Profile Updated: July 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Ncage Therapeutics Sp. z o.o. is a company based in Poland, with its head office in Krakow. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was established on November 18, 2019. There was a total growth of 12.02% in Ncage Therapeutics Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Profesora Michala Bobrzynskiego 14
Krakow; Malopolskie; Postal Code: 30-348

Contact Details: Purchase the Ncage Therapeutics Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ncage Therapeutics Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ncage Therapeutics Sp. z o.o. report to view the information.
Incorporation Date:
November 18, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
25.76%
Purchase this report to view the information.
22.94%
Purchase this report to view the information.
20.37%
Purchase this report to view the information.
13.18%
Company Performance
Financial values in the chart are available after Ncage Therapeutics Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-11.88%▼
Operating profit (EBIT)
-97.71%▼
EBITDA
-96.3%▼
Net Profit (Loss) for the Period
-98.96%▼
Total assets
12.02%▲
Total equity
-172.19%▼
Return on Equity (ROE)
-23.29%▼
Debt to Equity Ratio
58.74%▲
Quick Ratio
0.1%▲
Cash Ratio
-0.13%▼

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Selvita Services Sp. z o.o.
 
Sartorius Stedim Poland Sp. z o.o.
Endo Medical Sp. z o.o.
 
Modern Medicine Sp. z o.o.
Genegoggle Sp. z o.o.
 
"Bcd-M" Sp. z o.o.
4Cell Therapies S.A.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo